ARIX — Arix Bioscience Balance Sheet
0.000.00%
Last trade - 00:00FinancialsBalancedSmall CapMomentum Trap
- £145.62m
- £44.67m
- £0.11m
- 27
- 39
- 62
- 35
Annual balance sheet for Arix Bioscience, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2018 December 31st | C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 31 | 54.6 | 112 | 134 | 123 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.81 | 0.842 | 1.14 | 1.69 | 2.09 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 93.4 | 55.7 | 176 | 136 | 125 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.313 | 0.499 | 0.139 | 0.206 | 0.129 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 279 | 209 | 331 | 257 | 228 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9.28 | 6.15 | 2.23 | 1.6 | 1.92 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 9.28 | 7.11 | 2.5 | 1.72 | 1.93 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 270 | 202 | 328 | 255 | 226 |
| Total Liabilities & Shareholders' Equity | 279 | 209 | 331 | 257 | 228 |
| Total Common Shares Outstanding |